£1.7 million invested into new research projects

Published Date
Jenny Sharpe

We are delighted to announce that we are investing approximately £1.7 million into 10 new research projects that came out of our grant rounds. Last year we had two grant rounds, one for applications for research into any type of muscle-wasting condition, and a second to support research into a very rare condition called nemaline myopathy. Read more about the International Call for Nemaline Myopathy.

The projects were selected following a thorough peer review process using independent international experts, which included our Medical Research Committee. Our Lay Research Panel, who are affected directly or indirectly by a muscle-wasting condition, was also part of the assessment process. This ensures we are funding the best quality science that is relevant to people with muscle-wasting conditions. Read more about how we fund research.

The selected projects are focussed on several different conditions including Duchenne muscular dystrophy, Becker muscular dystrophy, myotonic dystrophy, facioscapulohumeral muscular dystrophy (FSHD), inherited neuropathy and nemaline myopathy.

We will be announcing more details about each of the 10 research projects over the next few weeks. As September is Charcot-Marie-Tooth (CMT) Awareness Month, we would like to share with you the first project, which is looking into CMT and other inherited neuropathies:

Professor Henry Houlden – Identifying and investigating the causes of inherited neuropathy

[Update 7 September 2016] As today is World Duchenne Awareness Day, we are pleased to announce the following new projects:

Dr Ros Quinlivan – Improving care for adults with Duchenne muscular dystrophy

Professor Dame Kay Davies – Identifying biomarkers to monitor the effectiveness of utrophin up-regulation

Dr Federica Montanaro – Predicting the impact of exon skipping on dystrophin function

[Update 3 November 2016] The rest of the new projects are as follows:

Dr Linda Popplewell – Development of molecular patches for the treatment of facioscapulohumeral muscular dystrophy

Dr Judith Sleeman – Understanding the nuclear changes that lead to myotonic dystrophy type 1

Professor Paul Maddison – Validating clinical markers for monitoring the progression of myotonic dystrophy type 1

Professor Matthew Wood – Developing an advanced molecular patch therapy for myotonic dystrophy type 1

Dr Carina Wallgren-Petterson – Improving the diagnosis of nebulin-related nemaline myopathy

Professor Coen Ottenheijm – Preventing muscle shrinkage in nebulin-related nemaline myopathy

It is only through your contributions that we can continue to fund the vital work that takes us closer to finding treatments for muscle-wasting conditions. Donate now and help to change the lives of thousands of people living with these conditions. Thank you for your support.

Keep in touch